UPDATE 1-Auris's tinnitus drug misses main goals in study; shares sink

Aug 18 (Reuters) - Auris Medical Holding AG said
its experimental drug for acute inner ear tinnitus missed the
main goals of a late-stage study, sending its shares down more
than 40 percent in...